Speier Discusses FDA and mHealth Utilization with Applied Clinical Trials

With the growth and increasing applications of mHealth come the need to regulate, and the biopharmaceutical industry and regulatory bodies such as the FDA are coming together to develop frameworks for mHealth utilization in clinical trials. Austin Speier, VP of Emerging Technologies at Precision for Medicine, spoke recently about mHealth regulatory pathways at PanAgora’s Mobile Innovations Summit; read the full article here.